Observational studyFrontiers in endocrinology2023

The role of bone modifying agents for secondary osteoporosis prevention and pain control in post-menopausal osteopenic breast cancer patients undergoing adjuvant aromatase inhibitors.

Antonio Galvano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.